diabetes
Coverage of diabetes in the Nexus archive.
- Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Approximately 36% of employers provide coverage for GLP-1 obesity drugs for both diabetes and weight loss in 2025, unchanged from the previous year and up from 34% in 2024. Many employers are finding ways to avoid expanding this coverage.
- Deep Dive Into Local Data Shows Diversity of Rural Health Issues in Georgia
A study by the Parkland Center for Clinical Innovation reveals rural Georgia residents face high vulnerability to chronic diseases like coronary heart disease and diabetes. The research highlights closures of rural hospitals and socioeconomic barriers such as low insurance coverage and poor internet access, contrasting with Texas's hospital distance challenges.
- Three deaths tied to Chicago-area heat wave
Three deaths in Chicago were linked to a recent heat wave, with autopsies showing heat stress as a complicating factor in each case. Health officials warned that extreme heat poses risks for individuals with chronic conditions and limited access to air conditioning. The heat wave began on June 29, referencing Chicago's 1995 heat wave that caused 739 deaths.
- A Registered Nurse Offers Free Blood Pressure and Diabetes Checks in Pasadena
A registered nurse offers free blood pressure and diabetes screenings at the Santa Catalina Branch Library in Pasadena on July 6 from 10 a.m. to noon. The event provides health counseling and aims to detect issues before they become emergencies.
- STAT+: A ‘historic’ FDA clearance raises the question: Is LLM the interface? Or the decision-maker?
UpDoc, a digital health company, received the first FDA clearance for medical software using patient-facing large language models (LLMs) in its diabetes management app. The app, which helps patients follow doctor-defined treatment plans, uses an LLM-based interface to provide treatment instructions based on user inputs like voice and text.
- Amputee found tied to his wheelchair, left to die in scorching Arizona heat, police say
A 33-year-old man in a wheelchair was found tied to his chair with plastic bags and died in extreme Phoenix heat. Police arrested one suspect for kidnapping and murder, with a second man believed involved. The victim had diabetes and a recent leg amputation, and witnesses reported seeing him tied up earlier.
- Amputee found tied to his wheelchair, left to die in scorching Arizona heat, police say
A 33-year-old man in a wheelchair was found tied to his chair with plastic bags and died in extreme Phoenix heat. Police arrested one suspect and are seeking another after witnesses reported seeing him tied up earlier. The victim had diabetes and a recent leg amputation, and his health reportedly declined before the incident.
- Amputee found tied to his wheelchair, left to die in scorching Arizona heat, police say
A 33-year-old man in a wheelchair, Aaron Goodyke, was found dead outside in Phoenix after being tied to his chair with plastic bags. Police arrested Hector Corrales on suspicion of kidnapping and murder, and an unidentified man is also suspected. Goodyke, who was diabetic and had a recent leg amputation, was seen tied up and mumbling earlier by witnesses before his death.
- How six months in Israeli jail changed this Palestinian journalist’s life forever
Mujahid Bani Mufleh, a Palestinian journalist detained in Israel for six months without charge, suffered physical and psychological abuse that left him severely weakened. After his release, he was hospitalized with a brain haemorrhage and stroke, which he attributes to the mistreatment during detention.
- CMC bags Centre of Excellence award for diabetes
The CMC has been awarded the Centre of Excellence status by both the International Diabetes Federation and the Indian Council of Medical Research for diabetes care.
- Common Cataract Myths Explained: What You Need to Know About Vision Changes
Cataracts are a common age-related vision condition caused by protein breakdown in the eye's lens, with symptoms like blurry vision and glare. They cannot be fully prevented but are treatable via effective surgery that replaces the cloudy lens with an artificial one. Routine eye exams are recommended for early detection.
- Judge rules government can't stop SNAP dollars from buying candy and sugary drinks
A federal judge ruled that the government cannot restrict Supplemental Nutrition Assistance Program (SNAP) benefits from being used to buy candy and sugary drinks, citing a legal conflict with Congress's definition of 'food.' The decision blocks restrictions in 23 states and challenges efforts by the Agriculture and Health Secretaries to promote healthier food choices through the 'Make America Healthy Again' campaign.
- Tennessee has one of the worst rates of heart disease mortality in the U.S., data shows
Tennessee ranks 6th in the U.S. for heart disease mortality, with 210 deaths per 100,000 people. Southern states, including Oklahoma, Mississippi, and Alabama, have the highest rates. Researchers link the trend to factors like diabetes, high blood pressure, obesity, and structural racism.
- How cognitive baseline testing can track brain health over time
Cognitive baseline testing measures thinking and memory to track brain health over time, with experts recommending it for individuals with dementia family history, traumatic brain injuries, or conditions like diabetes. Professional neuropsychological testing, lasting four hours, provides comprehensive insights, while self-administered tests are discouraged.
- How cognitive baseline testing can track brain health over time
Cognitive baseline testing measures thinking and memory at a specific time to track brain health changes over years, enabling early detection of potential issues. Experts recommend establishing a baseline early, particularly for those with family histories of dementia, traumatic brain injuries, or conditions like diabetes, as professional neuropsychological testing provides comprehensive insights.
- STAT+: Cadence raises $100 million to automate chronic disease care with regulated AI
Cadence, a digital health company, raised $100 million in funding led by Spark Capital, valuing the company at $1.23 billion. The investment aims to expand Cadence's chronic disease management programs and automate clinician work with AI, despite scrutiny over its billing model from the federal health department's watchdog and insurers like UnitedHealthcare.
- How inflation undermines Nigeria's sugar tax
Nigeria's sugary drinks tax, designed to curb rising diabetes rates, has been weakened by inflation, reducing its effectiveness. Experts argue the current tax is insufficient to alter consumer behavior and recommend higher levies and policy reforms.
- Fighting childhood obesity, for a healthier, longer life
Childhood obesity rates have risen from 1 in 20 in 1970 to 1 in 5 today, driven by factors like diet and exercise. Dr. Jonathan LaPook examines programs promoting healthy eating and physical activity to reduce obesity-related risks such as diabetes, heart disease, and cancer.
- Should everyone be on GLP-1s? What the science really tells us about cancer prevention and other benefits
GLP-1 drugs are being studied for expanded health benefits beyond diabetes and weight loss, including cancer prevention and addiction treatment. However, scientific understanding of their full potential remains incomplete.
- How many Americans can afford high-quality healthcare? A new poll finds the number has fallen
A new poll by the West Health-Gallup Affordability Index reveals that only 49% of U.S. adults could afford high-quality healthcare in 2025, down from 56% in 2021. Rising healthcare costs and financial burdens have left many Americans, like Twannetta Weaver and Inger Perez, struggling to balance medical expenses with other essential needs, with half of respondents expressing concern about affording care in 2026.
- A Chesapeake mom had trouble getting her son accommodations for diabetes. Then, she went to Richmond.
Jennifer Economy, a Chesapeake mother, encountered difficulties in obtaining diabetes accommodations for her son and subsequently joined a national organization advocating for updated school diabetes management laws. She traveled to Richmond to address the issue.
- 10 surprising ways diabetes and dementia are connected
Diabetes and dementia are closely linked, with insulin and glucose issues affecting brain energy supply, increasing inflammation, and damaging blood vessels associated with memory loss. Some diabetes medications may reduce dementia risk, offering new avenues for protecting brain health during aging.
- Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here’s who qualifies
Up to 14 million Medicare patients may qualify for GLP-1 drugs at $50 a month for weight loss. These drugs were previously available for diabetes but are now accessible for weight loss under Medicare.
- Diabetes Tied to Higher Death Risk After Solid Organ Transplant
Diabetes is associated with higher mortality risk in solid organ transplant recipients, affecting both pre-existing and new-onset cases across four major organs. The study highlights a significant link between diabetes and post-transplant death risk.
- New MLK hospital program brings amputations to zero for at-risk diabetic patients
A new program at MLK hospital has reduced amputations to zero for high-risk diabetic patients over four years, with only one patient requiring an amputation. The initiative improves health outcomes and avoids costly surgeries.
- New MLK hospital program brings amputations to zero for at-risk diabetic patients
A new MLK hospital program has significantly reduced amputations for high-risk diabetic patients, with only one amputation needed in four years. The initiative avoids costly surgeries and improves patient health outcomes.
- Nigeria: Abducted former general dies in captivity
Rabe Abubakar was abducted along with his wife by bandits in the northwest. The government stated he died from complications related to diabetes and hypertension.
- We rabbis demand the release of Palestinian Muslim community leader Salah Sarsour
A group of rabbis demands the release of Palestinian Muslim community leader Salah Sarsour, a legal permanent resident in Wisconsin detained by ICE since March 30. Sarsour, president of the Islamic Society of Milwaukee, faces medical neglect for diabetes in Indiana's Clay County Jail, where 51 people have died since 2025 due to inhumane conditions.
- Roche’s global survey highlights urgent need to shift diabetes care from disease treatment to mental wellbeing
Roche’s global survey emphasizes the need to prioritize mental wellbeing in diabetes care, as nearly one in ten people in Hong Kong live with diabetes. The city faces a growing public-health challenge due to an ageing population, shifting lifestyles, and a high number of undiagnosed cases.
- Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
Five diabetes experts were expelled from the American Diabetes Association annual meeting in New Orleans for distributing an editorial criticizing federal cuts to biomedical research. The incident has sparked backlash in the diabetes research and practice community, with the ADA's communications further worsening the situation.
- Dexcom RCT suggests CGM benefits for broad diabetes population
A Dexcom randomized controlled trial (RCT) indicates that continuous glucose monitoring (CGM) offers benefits for a broad population of diabetes patients. The study's findings suggest CGM could be advantageous beyond specific subgroups.
- GLP-1s appear to protect against cancer. Researchers are trying to figure out how
Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may prevent cancer and slow its progression by acting on brain and metabolic pathways beyond weight loss.
- Attorneys urge release of mosque leader, saying he’s been denied diabetes care in ICE custody
Attorneys for the president of Wisconsin's largest mosque claim he is being denied basic medical care for diabetes in U.S. Immigration and Customs Enforcement custody, resulting in a 30-pound weight loss over two months.
- Attorneys urge release of mosque leader, saying he's been denied diabetes care in ICE custody
Attorneys for Salah Sarsour, a Palestinian-born legal permanent resident detained by ICE, claim he is being denied consistent diabetes care and has lost 30 pounds in detention. They argue his detention is based on baseless claims and allege religious discrimination in the Indiana jail where he is held.
- STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca's investigational GLP-1 pill, elecoglipron, demonstrated significant weight loss in a Phase 2 obesity trial (11.2% after 36 weeks) and improved blood sugar control in a diabetes trial (1.74 percentage-point A1C reduction). Results were compared to oral Ozempic, which showed a smaller A1C decrease in the same study.
- Revealed: The most dangerous and addictive vape flavours... and the fruit 'sweet' concoctions linked to diabetes, cancer and heart and lung disease
The article reveals that certain vape flavours are linked to severe health risks including diabetes, cancer, heart, and lung diseases. These flavours are identified as both dangerous and addictive.
- Police Remove Researchers From Diabetes Conference
Police removed researchers from a diabetes conference. The incident was reported by Susan H. Greenberg.
- The promises and pitfalls of GLP-1 drugs
GLP-1 drugs, approved 20 years ago for diabetes treatment, have helped over 30 million U.S. patients reduce weight but are associated with troubling side effects.
- The promises and pitfalls of GLP-1 drugs
GLP-1 drugs, approved 20 years ago for diabetes, have helped over 30 million U.S. patients reduce weight but are associated with troubling side effects. Experts suggest potential use in treating obesity-related diseases like cancer, though patient reactions vary widely.
- Finerenone Also Slows Kidney Decline in Diabetes-Free Patients
Finerenone (Kerendia) slowed kidney function decline in adults with chronic kidney disease (CKD) who do not have diabetes, according to the FIND-CKD trial. The trial demonstrated a reduced annual rate of change in estimated kidney function by month 32.